Literature DB >> 14519103

Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Lisa M Shantz1.   

Abstract

ODC (ornithine decarboxylase) activity is induced following ras activation. However, the Ras effector pathways responsible are unknown. These experiments used NIH-3T3 cells expressing partial-loss-of-function Ras mutants to activate selectively pathways downstream of Ras and examined the contribution of each pathway to ODC induction. Overexpression of Ras12V, a constitutively active mutant, resulted in ODC activities up to 20-fold higher than controls. Stable transfections of Ras partial-loss-of-function mutants and constitutively active forms of MEK (MAPK kinase) and Akt indicated that activation of more than one Ras effector pathway is necessary for the complete induction of ODC activity. The increase in ODC activity in Ras12V-transformed cells is not owing to a substantial change in ODC protein half-life, which increased by <2-fold. Northern-blot analysis and reporter assays suggested that the mechanism of ODC induction involves both a modest increase in the transcription of ODC mRNA and a much more considerable increase in the translation of mRNA into protein. ODC transcription was controlled through a pathway dependent on Raf/MEK/ERK (where ERK stands for extracellular-signal-regulated kinase) activation, whereas activation of the phosphoinositide 3-kinase and the Raf/MEK/ERK pathways were necessary for translational regulation of ODC. The increase in ODC synthesis was accompanied by changes in phosphorylation of eukaryotic initiation factor 4E and its binding protein 4E-BP1. Results show that the phosphoinositide 3-kinase pathway regulates phosphorylation of both proteins, whereas the Raf/MEK/ERK pathway affects only the eukaryotic initiation factor 4E phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14519103      PMCID: PMC1223852          DOI: 10.1042/BJ20030778

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Translational control of the antiapoptotic function of Ras.

Authors:  V A Polunovsky; A C Gingras; N Sonenberg; M Peterson; A Tan; J B Rubins; J C Manivel; P B Bitterman
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

2.  Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells.

Authors:  H Sheng; J Shao; R N DuBois
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

3.  Insulin signal transduction pathways and insulin-induced gene expression.

Authors:  Adam B Keeton; Maggie O Amsler; Derwei Y Venable; Joseph L Messina
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

4.  Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase.

Authors:  R A Hurta
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

5.  Polyamine depletion arrests growth of IEC-6 and Caco-2 cells by different mechanisms.

Authors:  R M Ray; S A McCormack; L R Johnson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

6.  Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA.

Authors:  Gert C Scheper; Barbara van Kollenburg; Jianzhong Hu; Yunjing Luo; Dixie J Goss; Christopher G Proud
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

7.  The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites.

Authors:  Terence P Herbert; Andrew R Tee; Christopher G Proud
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

8.  Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors.

Authors:  F Flamigni; A Facchini; E Giordano; B Tantini; C Stefanelli
Journal:  Biochem Pharmacol       Date:  2001-01-01       Impact factor: 5.858

9.  Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.

Authors:  D J Feith; L M Shantz; A E Pegg
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

10.  Distinct signalling pathways mediate insulin and phorbol ester-stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells.

Authors:  T P Herbert; G R Kilhams; I H Batty; C G Proud
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

View more
  17 in total

1.  Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells.

Authors:  Sofia Origanti; Shannon L Nowotarski; Theresa D Carr; Suzanne Sass-Kuhn; Lan Xiao; Jian-Ying Wang; Lisa M Shantz
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

Review 2.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

3.  Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.

Authors:  Shannon L Nowotarski; Lisa M Shantz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

4.  Knockout of Raptor destabilizes ornithine decarboxylase mRNA and decreases binding of HuR to the ODC transcript in cells exposed to ultraviolet-B irradiation.

Authors:  Shannon L Nowotarski; Robert P Feehan; Christopher Presloid; Lisa M Shantz
Journal:  Biochem Biophys Res Commun       Date:  2018-10-09       Impact factor: 3.575

Review 5.  The proximal tubule in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

6.  Posttranscriptional regulation of ornithine decarboxylase.

Authors:  Shannon L Nowotarski; Sofia Origanti; Lisa M Shantz
Journal:  Methods Mol Biol       Date:  2011

Review 7.  Polyamines and nonmelanoma skin cancer.

Authors:  Susan K Gilmour
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-29       Impact factor: 4.219

8.  Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats: the role of mitochondrial permeability transition pores.

Authors:  Hao Zhang; Guo Xue; Weihua Zhang; Lina Wang; Hong Li; Li Zhang; Fanghao Lu; Shuzhi Bai; Yan Lin; Yu Lou; Changqing Xu; Yajun Zhao
Journal:  Mol Cell Biochem       Date:  2014-01-24       Impact factor: 3.396

Review 9.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

10.  Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.

Authors:  Dong Joon Kim; Eunmiri Roh; Mee-Hyun Lee; Naomi Oi; Do Young Lim; Myoung Ok Kim; Young-Yeon Cho; Angelo Pugliese; Jung-Hyun Shim; Hanyong Chen; Eun Jin Cho; Jong-Eun Kim; Sun Chul Kang; Souren Paul; Hee Eun Kang; Ji Won Jung; Sung-Young Lee; Sung-Hyun Kim; Kanamata Reddy; Young Il Yeom; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.